openPR Logo
Press release

Neurodegenerative Disorder Therapeutics Market 2023 - By Market Overview, Business Opportunities, Industry Share And Forecast To 2032

10-03-2023 08:01 AM CET | Health & Medicine

Press release from: The Business research company

Neurodegenerative Disorder Therapeutics Market

Neurodegenerative Disorder Therapeutics Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Neurodegenerative Disorder Therapeutics Global Market Report 2023 identifies ncreased prevalence of neurodegenerative among the global population as the major driver for the Neurodegenerative Disorder Therapeutics market's growth in the forecast period. The increase in the geriatric population attributes to the increased prevalence of neurodegenerative disorders. According to World Population Prospects, the number of people above 60 years of age will increase to 2.1 billion in 2050 and it is expected that people aged over 80 years will triple to 425 million in 2050.

The global neurodegenerative disorder therapeutics market size grew from $15.86 billion in 2022 to $17.14 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the neurodegenerative disorder therapeutics is expected to grow from $23.65 billion in 2027 at a CAGR of 8.4%.

Download Free Sample Of Neurodegenerative Disorder Therapeutics Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp

Major competitors in the Neurodegenerative Disorder Therapeutics market are Biogen, Pfizer, Novartis, Sanofi, Teva Pharmaceutical, UCB, Hoffmann- La Roche Ltd., ACADIA Pharmaceuticals Inc., Lundeck A/S.

A key trend in the Neurodegenerative Disorder Therapeutics market includes strategic partnerships with government and non-government organizations. The companies in the neurodegenerative disorder therapeutics market are also increasing their collaboration with other players in the market to increase their capabilities for research and development activities to develop new and more effective therapeutic solutions to treat neurodegenerative disorders. For instance, in July 2022, NRG Therapeutics, a UK-based drug discovery company focussed on therapeutic approaches, partnered with Domainex, a UK-based drug discovery service, to develop neurodegenerative disease treatment. For the treatment of Parkinson's disease, motor neurone disease (MND), and other incapacitating chronic neurodegenerative conditions, the firms would work together to develop novel small molecule disease-modifying medications.

Read More On The Global Neurodegenerative Disorder Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

The Neurodegenerative Disorder Therapeutics market is segmented -

• By Indication Type: Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
• By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
• By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Neurodegenerative Disorder Therapeutics market.

The Business Research Company's "Global Neurodegenerative Disorder Therapeutics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Neurodegenerative Disorder Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2818

The Table Of Content For The Neurodegenerative Disorder Therapeutics Market Include:

1. Executive Summary
2. Neurodegenerative Disorder Therapeutics Market Characteristics
3. Neurodegenerative Disorder Therapeutics Market Trends And Strategies
4. Neurodegenerative Disorder Therapeutics Market - Macro Economic Scenario
5. Neurodegenerative Disorder Therapeutics Market Size And Growth
……………………………………..
26. Africa Neurodegenerative Disorder Therapeutics Market
27. Neurodegenerative Disorder Therapeutics Market Competitive Landscape And Company Profiles
28. Neurodegenerative Disorder Therapeutics Pipeline Analysis
29. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market
30. Neurodegenerative Disorder Therapeutics Market Future Outlook and Potential Analysis

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurodegenerative Disorder Therapeutics Market 2023 - By Market Overview, Business Opportunities, Industry Share And Forecast To 2032 here

News-ID: 3232379 • Views:

More Releases from The Business research company

Shoe Care Market on Track for Strong Growth, Estimated to Grow at 4.8% CAGR Through 2029
Shoe Care Market on Track for Strong Growth, Estimated to Grow at 4.8% CAGR Thro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Shoe Care Market Through 2025? The shoe care market has expanded steadily in recent years. It will increase from $4.57 billion in 2024 to $4.77 billion in 2025, with a CAGR of 4.4%. Growth historically was supported by higher disposable incomes, growing
Plywood Market Poised to Hit $163.8 Billion by 2029 with Accelerating Growth Trends
Plywood Market Poised to Hit $163.8 Billion by 2029 with Accelerating Growth Tre …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_ _x000D_ Plywood Market Size Growth Forecast: What to Expect by 2025?_x000D_ The plywood market has expanded steadily in recent years, moving from $125.43 billion in 2024 to $131.63 billion in 2025 at a CAGR of 4.9%. Its past growth was driven by rising populations, residential construction activity, low-interest rates, and
Increasing Demand For On-The-Go Food And Beverage Products Fueled The Spouted Pouch Market Driving Market Acceleration in the Spouted Pouches Industry, 2025
Increasing Demand For On-The-Go Food And Beverage Products Fueled The Spouted Po …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Spouted Pouches Market Size By 2025? The spouted pouches market has shown strong growth in recent years. It is predicted to grow from $3.44 billion in 2024 to $3.75 billion in 2025, with a CAGR of 8.9%. How Big Is the Spouted Pouches Market Size Expected
Impact Of Rising Residential Housing Completions On The Entrance Matting Market: Transformative Forces Shaping the Entrance Matting Market Landscape in 2025
Impact Of Rising Residential Housing Completions On The Entrance Matting Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Entrance Matting Industry Market Size Be by 2025? The entrance matting market has recorded consistent growth in recent years. It is projected to expand from $7.12 billion in 2024 to $7.53 billion in 2025, achieving a CAGR of 5.8%. Contributing factors in the historic period included

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant